Oncoceutics Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees
Oncoceutics, Inc. is a clinical-stage drug discovery and development company with a novel class of selective G protein-coupled receptor antagonists for oncology. The first lead compound to result from this program is ONC201, an orally active DRD2 small molecule antagonist that is well-tolerated and effective against advanced cancers.